Logo image
Technology landscape of pediatric mechanical circulatory support devices: A systematic review 2010-2021
Journal article   Open access   Peer reviewed

Technology landscape of pediatric mechanical circulatory support devices: A systematic review 2010-2021

Thomas Palazzolo, Matthew Hirschhorn, Ellen Garven, Steven Day, Randy M. Stevens, Joseph Rossano, Vakhtang Tchantchaleishvili and Amy L. Throckmorton
Artificial organs, v 46(8), pp 1475-1490
14 Apr 2022
PMID: 35357020
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256769View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Engineering Engineering, Biomedical Life Sciences & Biomedicine Science & Technology Technology Transplantation
Background Mechanical circulatory support (MCS) devices, such as ventricular assist devices (VADs) and total artificial hearts (TAHs), have become a vital therapeutic option in the treatment of end-stage heart failure for adult patients. Such therapeutic options continue to be limited for pediatric patients. Clinicians initially adapted or scaled existing adult devices for pediatric patients; however, these adult devices are not designed to support the anatomical structure and varying flow capacities required for this population and are generally operated "off-design," which risks complications such as hemolysis and thrombosis. Devices designed specifically for the pediatric population which seek to address these shortcomings are now emerging and gaining FDA approval. Methods To analyze the competitive landscape of pediatric MCS devices, we conducted a systematic literature review. Approximately 27 devices were studied in detail: 8 were established or previously approved designs, and 19 were under development (11 VADs, 5 Fontan assist devices, and 3 TAHs). Results Despite significant progress, there is still no pediatric pump technology that satisfies the unique and distinct design constraints and requirements to support pediatric patients, including the wide range of patient sizes, increased cardiovascular demand with growth, and anatomic and physiologic heterogeneity of congenital heart disease. Conclusions Forward-thinking design solutions are required to overcome these challenges and to ensure the translation of new therapeutic MCS devices for pediatric patients.

Metrics

17 Record Views
19 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Engineering, Biomedical
Transplantation
Logo image